Drugs / Wild strain IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04386707 Comparator | May 2020 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wild strain IPV | “Wild strain IPV (wIPV）manufactured by Sanofi Pasteur S.A.” NCT04386707 ↗ |
| Known as | wIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04386707 ↗ |
| Modality | Vaccine | “Wild strain IPV (wIPV）manufactured by Sanofi Pasteur S.A.” NCT04386707 ↗ |